16. Dezember 2025
Fähzan Ahmad • 16. Dezember 2025
How scale exposes process assumptions GMP never forgives.

Many cosmetic products pass pilot production and collapse at scale. This is not bad luck—it is unvalidated process transfer.
Scale-up changes shear forces, mixing times, thermal gradients, and filling behavior. GMP requires that these changes be assessed, validated, and documented. Yet many manufacturers rely on “same formula, bigger tank” logic—which regulators explicitly reject [ISO 22716, Clause 12].
Failure modes include phase separation, viscosity drift, preservative inefficacy, and fill-weight variability. When these occur without predefined controls, GMP is breached—even if the product remains saleable.
A GMP-compliant scale-up defines:
- critical process parameters (CPPs)
- acceptable operating ranges
- in-process controls
- change control logic
At Makrolife Biotech, GMP scale-up is treated as a new risk state, not a linear extension. This prevents late-stage failures and audit findings.
GMP does not scale automatically.
Processes must.








